Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Blood bank
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Medical advances=== [[File:Private Roy W. Humphrey of Toledo, Ohio is being given blood plasma after he was wounded by shrapnel in Sicily on 8-9-43 - NARA - 197268.jpg|thumb|Wounded soldier is given [[blood plasma]] in [[Sicily]], 1943.]] A blood collection program was initiated in the US in 1940 and [[Edwin Cohn]] pioneered the process of [[blood fractionation]]. He worked out the techniques for isolating the [[serum albumin]] fraction of [[blood plasma]], which is essential for maintaining the [[oncotic pressure|osmotic pressure]] in the [[blood vessel]]s, preventing their collapse. The use of blood plasma as a substitute for whole blood and for transfusion purposes was proposed as early as 1918, in the correspondence columns of the ''[[British Medical Journal]]'', by Gordon R. Ward. At the onset of [[World War II]], liquid plasma was used in Britain. A large project, known as 'Blood for Britain' began in August 1940 to collect blood in [[New York City]] hospitals for the export of plasma to [[United Kingdom|Britain]]. A dried plasma package was developed, which reduced breakage and made the transportation, packaging, and storage much simpler.<ref>{{cite web|url=http://history.amedd.army.mil/booksdocs/wwii/blood/chapter1.htm|title=Office of Medical History|website=history.amedd.army.mil|access-date=4 May 2018|url-status=dead|archive-url=https://web.archive.org/web/20161218150653/http://history.amedd.army.mil/booksdocs/wwii/blood/chapter1.htm|archive-date=18 December 2016}}</ref> [[File:Charles R Drew portrait.png|thumb|left|[[Charles R. Drew]] oversaw the production of blood plasma for shipping to Britain during WW2.]] The resulting dried plasma package came in two tin cans containing 400 cc bottles. One bottle contained enough [[distilled water]] to reconstitute the dried plasma contained within the other bottle. In about three minutes, the plasma would be ready to use and could stay fresh for around four hours.<ref>{{cite web|url=http://history.amedd.army.mil/booksdocs/wwii/blood/chapter7.htm|title=Office of Medical History|website=history.amedd.army.mil|access-date=4 May 2018|url-status=dead|archive-url=https://web.archive.org/web/20170609105142/http://history.amedd.army.mil/booksdocs/wwii/blood/chapter7.htm|archive-date=9 June 2017}}</ref> [[Charles R. Drew]] was appointed medical supervisor, and he was able to transform the [[test tube]] methods into the first successful mass production technique. Another important breakthrough came in 1939β40 when [[Karl Landsteiner]], Alex Wiener, Philip Levine, and R.E. Stetson discovered the [[Rh blood group system]], which was found to be the cause of the majority of [[transfusion reaction]]s up to that time. Three years later, the introduction by [[John Freeman Loutit|J.F. Loutit]] and Patrick L. Mollison of [[acid-citrate-dextrose]] (ACD) solution, which reduced the volume of anticoagulant, permitted transfusions of greater volumes of blood and allowed longer-term storage. Carl Walter and W.P. Murphy Jr. introduced the [[plastic bag]] for blood collection in 1950. Replacing breakable [[glass]] bottles with durable plastic bags allowed for the evolution of a collection system capable of safe and easy preparation of multiple blood components from a single unit of whole blood. Further extending the shelf life of stored blood up to 42 days was an anticoagulant preservative, CPDA-1, introduced in 1979, which increased the blood supply and facilitated resource-sharing among blood banks.<ref>{{Cite journal|last1=Sugita|first1=Yoshiki|last2=Simon|first2=Ernest R.|date=1965|title=The Mechanism of Action of Adenine in Red Cell Preservation|journal=Journal of Clinical Investigation|volume=44|issue=4|pages=629β642|issn=0021-9738|pmid=14278179|pmc=292538|doi=10.1172/JCI105176}}</ref><ref>{{Cite journal|last1=Simon|first1=Ernest R.|last2=Chapman|first2=Robert G.|last3=Finch|first3=Clement A.|date=1962|title=Adenine in Red Cell Preservation|journal=Journal of Clinical Investigation|volume=41|issue=2|pages=351β359|issn=0021-9738|pmid=14039291|pmc=289233|doi=10.1172/JCI104489}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)